Short Interest in Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Expands By 17.6%

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) was the recipient of a large growth in short interest in November. As of November 15th, there was short interest totalling 86,800 shares, a growth of 17.6% from the October 31st total of 73,800 shares. Based on an average daily trading volume, of 81,500 shares, the days-to-cover ratio is currently 1.1 days.

Ekso Bionics Stock Performance

EKSO traded down $0.01 during midday trading on Tuesday, reaching $0.68. The company had a trading volume of 41,307 shares, compared to its average volume of 114,811. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.14 and a current ratio of 2.81. The stock has a market cap of $14.96 million, a PE ratio of -1.06 and a beta of 1.43. Ekso Bionics has a 12-month low of $0.66 and a 12-month high of $3.13. The business has a 50-day moving average price of $0.93 and a two-hundred day moving average price of $1.06.

Ekso Bionics (NASDAQ:EKSO) last posted its earnings results on Monday, October 28th. The company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.02). Ekso Bionics had a negative return on equity of 83.09% and a negative net margin of 62.95%. The firm had revenue of $4.13 million for the quarter, compared to the consensus estimate of $6.00 million. During the same period last year, the company posted ($0.24) EPS. On average, sell-side analysts expect that Ekso Bionics will post -0.48 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on EKSO shares. Lake Street Capital dropped their target price on shares of Ekso Bionics from $2.50 to $2.00 and set a “buy” rating on the stock in a report on Tuesday, October 29th. HC Wainwright dropped their price target on shares of Ekso Bionics from $10.00 to $9.00 and set a “buy” rating for the company in a research note on Tuesday, October 29th. Finally, StockNews.com initiated coverage on shares of Ekso Bionics in a research report on Wednesday, November 27th. They set a “hold” rating for the company.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.